The Journal of Allergy and Clinical Immunology
Volume 117, Issue 4 , Pages 767-773 , April 2006

Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 Summer Olympics

  • Sandra D. Anderson, PhD, DSc

      Affiliations

    • From the Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown
    • Corresponding Author InformationReprint requests: Sandra D. Anderson, PhD, DSc, Department of Respiratory Medicine, E 11, Royal Prince Alfred Hospital, Camperdown NSW 2050, Australia.
    • ,
  • Malcolm Sue-Chu, MB ChB, PhD

      Affiliations

    • Department of Lung Medicine, St Olavs Hospital, Trondheim University Hospital, Trondheim
    • ,
  • Clare P. Perry, BSc, Dip Ed

      Affiliations

    • From the Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown
    • ,
  • Christina Gratziou, MD, PhD

      Affiliations

    • Pulmonary and Critical Care Department, Asthma and Allergy Center, Medical School, University of Athens
    • ,
  • Pascale Kippelen, PhD

      Affiliations

    • From the Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown
    • ,
  • Don C. McKenzie, MD, PhD

      Affiliations

    • Division of Sports Medicine, The University of British Columbia, Vancouver
    • ,
  • Ken C. Beck, PhD

      Affiliations

    • Guidant Corp, St Paul
    • ,
  • Ken D. Fitch, MBBS, MD

      Affiliations

    • School of Human Movement and Exercise Science, University of Western Australia, Nedlands

Received 22 July 2005 ,Revised 15 December 2005 ,Accepted 19 December 2005.

References 

  1. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33:208–213
  2. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol. 2002;110:374–380
  3. Evans DW, Salome CM, King GG, Rimmer SJ, Seale JP, Woolcock AJ. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax. 1997;52:136–142
  4. Anderson SD, Brannan JD. Long-acting beta2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Paediatr Drugs. 2004;6:161–175
  5. Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R, McKenzie D, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2 agonists prior to an event at the 2002 Winter Olympics. J Allergy Clin Immunol. 2003;111:44–49
  6. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6:5–40
  7. Anderson SD, Lambert S, Brannan JD, Wood RJ, Koskela H, Morton AR, et al. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices. Med Sci Sports Exerc. 2001;33:893–900
  8. Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med. 2001;35:344–347
  9. Anderson SD, Brannan JD. Methods for “indirect” challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24:63–90
  10. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J. 1993;6:53–83
  11. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing—1999. Am J Respir Crit Care Med. 2000;161:309–329
  12. Altman DG. Practical statistics for medical research. 1st ed.. Oxford: Oxford University Press; 1991;
  13. International Study of Asthma and Allergies in Childhood . Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet. 1998;351:1225–1232
  14. Weiler J, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 Summer Games. J Allergy Clin Immunol. 1998;102:722–726
  15. Dickinson JW, Whyte GP, McConnell AK, Harries MG. Impact of changes in the IOC-MC asthma criteria: a British perspective. Thorax. 2005;60:629–632
  16. Anderson SD. Exercise-induced asthma in children: a marker of airway inflammation. Med J Aust. 2002;177(suppl):S61–S63
  17. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep. 2005;5:116–122
  18. Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT. Desensitisation of mast cell β2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol. 2004;141:163–171
  19. Caillaud C, Le Creff C, Legros P, Denjean A. Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists. Can J Appl Physiol. 2003;28:793–806
  20. Persson CG, Erjefalt JS, Alkner U, Baumgarten CM, Greiff L, Gistafsson B, et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy. 1991;21:17–24
  21. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is ……. J Allergy Clin Immunol. 2000;106:453–459
  22. Rundell KW, Anderson SD, Spiering BA, Judelson DA. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest. 2004;125:909–915
  23. Langdeau J-B, Turcotte H, Bowie DM, Jobin J, Desgagné P, Boulet L-P. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161:1479–1484
  24. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol. 1992;89:23–30
  25. Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, et al. The European Community Respiratory Health Survey: what are the main results so far?. Eur Respir J. 2001;18:598–611
  26. Reddel HK, Jenkins CR, Marks GB, Ware SI, Xuan W, Salome CM, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J. 2000;16:226–235
  27. van Grunsven PM, van Schayck CP, Molema J, Akkermans RP, van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with “corticosteroid naïve” mild asthma: a meta-analysis. Thorax. 1999;54:316–322
  28. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther. 1999;83:153–179
  29. Sue-Chu M, Karjalainen E-M, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airways inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross country skiers. Respiration. 2000;67:417–425
  30. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 1995;154:4719–4725
  31. Bonsignore MR, Morici G, Vignola AM, Riccobono L, Bonanno A, Profita M, et al. Increased airway inflammatory cells in endurance athletes: what do they mean?. Clin Exp Allergy. 2003;33:14–21
  32. Pelligrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968
  33. American Thoracic Society . Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202–1218
  34. Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis. 1983;128:153–157
  35. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med. 1998;32:125–129
  36. Crapo RO, Hankinson JL, Irvin C, MacIntyre NR, Voter KZ, Wise RA, et al. Standardization of spirometry. 1994 Update. The Official Statement of the American Thoracic Society. Am J Respir Crit Care Med. 1994;152:1107–1136
  37. Smith CM, Anderson SD. Inhalational challenge using hypertonic saline in asthmatic subjects: a comparison with responses to hyperpnoea, methacholine and water. Eur Respir J. 1990;3:144–151
  38. Holzer K, Anderson SD, Chan H-K, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003;167:534–547
  39. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet. 2004;364:1505–1512

 Supported by the International Olympic Committee Medical Commission.Disclosure of potential conflict of interest: S. Anderson has consulting arrangements with Pharmaxis Ltd; owns stock in Pharmaxis Ltd; is inventor of a bronchial hyperresponsiveness test, patent owned by her employer, Central Sydney Area Health Service and licensed to Pharmaxis; and has received grant support from National Health and Medical Research Council of Australia. No Conflict of Interest disclosure statement was received from C. Gratziou. The rest of the authors have declared they have no conflict of interest.

PII: S0091-6749(06)00177-1

doi: 10.1016/j.jaci.2005.12.1355

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 4 , Pages 767-773 , April 2006

Article Tools

* Image Usage & Resolution